Colleen A Lawton

Summary

Affiliation: Medical College of Wisconsin
Country: USA

Publications

  1. ncbi Long-term treatment sequelae after external beam irradiation with or without hormonal manipulation for adenocarcinoma of the prostate: analysis of radiation therapy oncology group studies 85-31, 86-10, and 92-02
    Colleen A Lawton
    Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI 53226, USA
    Int J Radiat Oncol Biol Phys 70:437-41. 2008
  2. ncbi Results of a phase II trial of transrectal ultrasound-guided permanent radioactive implantation of the prostate for definitive management of localized adenocarcinoma of the prostate (radiation therapy oncology group 98-05)
    Colleen A Lawton
    Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI 53226, USA
    Int J Radiat Oncol Biol Phys 67:39-47. 2007
  3. ncbi Long-term results of an RTOG Phase II trial (00-19) of external-beam radiation therapy combined with permanent source brachytherapy for intermediate-risk clinically localized adenocarcinoma of the prostate
    Colleen A Lawton
    Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI, USA
    Int J Radiat Oncol Biol Phys 82:e795-801. 2012
  4. ncbi Long-term results of a phase II trial of ultrasound-guided radioactive implantation of the prostate for definitive management of localized adenocarcinoma of the prostate (RTOG 98-05)
    Colleen A Lawton
    Radiation Oncology Medical College of Wisconsin, Milwaukee, WI 53226, USA
    Int J Radiat Oncol Biol Phys 81:1-7. 2011
  5. ncbi An update of the phase III trial comparing whole pelvic to prostate only radiotherapy and neoadjuvant to adjuvant total androgen suppression: updated analysis of RTOG 94-13, with emphasis on unexpected hormone/radiation interactions
    Colleen A Lawton
    Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI 53226, USA
    Int J Radiat Oncol Biol Phys 69:646-55. 2007
  6. ncbi Early initiation of salvage hormone therapy influences survival in patients who failed initial radiation for locally advanced prostate cancer: A secondary analysis of RTOG protocol 86-10
    William U Shipley
    Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA 02114, USA
    Int J Radiat Oncol Biol Phys 64:1162-7. 2006
  7. ncbi Androgen suppression plus radiation versus radiation alone for patients with stage D1/pathologic node-positive adenocarcinoma of the prostate: updated results based on national prospective randomized trial Radiation Therapy Oncology Group 85-31
    Colleen A Lawton
    Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI 53226, USA
    J Clin Oncol 23:800-7. 2005
  8. ncbi Ten-year follow-up of radiation therapy oncology group protocol 92-02: a phase III trial of the duration of elective androgen deprivation in locally advanced prostate cancer
    Eric M Horwitz
    Fox Chase Cancer Center, Department of Radiation Oncology, 333 Cottman Ave, Philadelphia, PA 19111 2497, USA
    J Clin Oncol 26:2497-504. 2008
  9. ncbi A descriptive analysis of postimplant dosimetric parameters from Radiation Therapy Oncology Group P0019
    W Robert Lee
    Department of Radiation Oncology, Duke University Medical Center, Durham, NC 27710, USA
    Brachytherapy 5:239-43. 2006
  10. ncbi Hormones and radiation therapy in locally advanced adenocarcinoma of the prostate
    Colleen A Lawton
    Medical College of Wisconsin, Radiation Oncology, Milwaukee, WI 53226, USA
    Semin Radiat Oncol 13:141-51. 2003

Detail Information

Publications17

  1. ncbi Long-term treatment sequelae after external beam irradiation with or without hormonal manipulation for adenocarcinoma of the prostate: analysis of radiation therapy oncology group studies 85-31, 86-10, and 92-02
    Colleen A Lawton
    Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI 53226, USA
    Int J Radiat Oncol Biol Phys 70:437-41. 2008
    ..We analyzed three large Radiation Therapy Oncology Group (RTOG) studies (85-31, 86-10, and 92-02) to try to address these issues...
  2. ncbi Results of a phase II trial of transrectal ultrasound-guided permanent radioactive implantation of the prostate for definitive management of localized adenocarcinoma of the prostate (radiation therapy oncology group 98-05)
    Colleen A Lawton
    Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI 53226, USA
    Int J Radiat Oncol Biol Phys 67:39-47. 2007
    ....
  3. ncbi Long-term results of an RTOG Phase II trial (00-19) of external-beam radiation therapy combined with permanent source brachytherapy for intermediate-risk clinically localized adenocarcinoma of the prostate
    Colleen A Lawton
    Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI, USA
    Int J Radiat Oncol Biol Phys 82:e795-801. 2012
    ..This report defines the long-term results of this trial...
  4. ncbi Long-term results of a phase II trial of ultrasound-guided radioactive implantation of the prostate for definitive management of localized adenocarcinoma of the prostate (RTOG 98-05)
    Colleen A Lawton
    Radiation Oncology Medical College of Wisconsin, Milwaukee, WI 53226, USA
    Int J Radiat Oncol Biol Phys 81:1-7. 2011
    ....
  5. ncbi An update of the phase III trial comparing whole pelvic to prostate only radiotherapy and neoadjuvant to adjuvant total androgen suppression: updated analysis of RTOG 94-13, with emphasis on unexpected hormone/radiation interactions
    Colleen A Lawton
    Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI 53226, USA
    Int J Radiat Oncol Biol Phys 69:646-55. 2007
    ..This trial was also designed to test the hypothesis that neoadjuvant hormonal therapy (NHT) followed by concurrent total androgen suppression and RT improves PFS compared with RT followed by adjuvant hormonal therapy (AHT) by > or =10%...
  6. ncbi Early initiation of salvage hormone therapy influences survival in patients who failed initial radiation for locally advanced prostate cancer: A secondary analysis of RTOG protocol 86-10
    William U Shipley
    Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA 02114, USA
    Int J Radiat Oncol Biol Phys 64:1162-7. 2006
    ....
  7. ncbi Androgen suppression plus radiation versus radiation alone for patients with stage D1/pathologic node-positive adenocarcinoma of the prostate: updated results based on national prospective randomized trial Radiation Therapy Oncology Group 85-31
    Colleen A Lawton
    Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI 53226, USA
    J Clin Oncol 23:800-7. 2005
    ..To update the effect of immediate androgen suppression in conjunction with standard external-beam irradiation versus radiation alone on a group of histologically lymph node-positive patients with adenocarcinoma of the prostate...
  8. ncbi Ten-year follow-up of radiation therapy oncology group protocol 92-02: a phase III trial of the duration of elective androgen deprivation in locally advanced prostate cancer
    Eric M Horwitz
    Fox Chase Cancer Center, Department of Radiation Oncology, 333 Cottman Ave, Philadelphia, PA 19111 2497, USA
    J Clin Oncol 26:2497-504. 2008
    ..To determine whether adding 2 years of androgen-deprivation therapy (ADT) improved outcome for patients electively treated with ADT before and during radiation therapy (RT)...
  9. ncbi A descriptive analysis of postimplant dosimetric parameters from Radiation Therapy Oncology Group P0019
    W Robert Lee
    Department of Radiation Oncology, Duke University Medical Center, Durham, NC 27710, USA
    Brachytherapy 5:239-43. 2006
    ..To date, there are few descriptive analyses of postimplant dosimetry from multi-institutional clinical trials. The purpose of this report is to describe the postimplant dosimetry achieved in Radiation Therapy Oncology Group (RTOG) 0019...
  10. ncbi Hormones and radiation therapy in locally advanced adenocarcinoma of the prostate
    Colleen A Lawton
    Medical College of Wisconsin, Radiation Oncology, Milwaukee, WI 53226, USA
    Semin Radiat Oncol 13:141-51. 2003
    ..Finally, the current recommendations for the use of hormonal manipulation combined with radiation therapy in locally advanced adenocarcinoma of the prostate is described...
  11. ncbi Impact of computed tomography image quality on image-guided radiation therapy based on soft tissue registration
    Natalya V Morrow
    Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA
    Int J Radiat Oncol Biol Phys 82:e733-8. 2012
    ..We explore how CT image quality affects patient repositioning and CTV-to-PTV margins in soft tissue registration-based IGRT for prostate cancer patients...
  12. ncbi A research agenda for radiation oncology: results of the radiation oncology institute's comprehensive research needs assessment
    Reshma Jagsi
    Department of Radiation Oncology, University of Michigan, Ann Arbor, MI 48109, USA
    Int J Radiat Oncol Biol Phys 84:318-22. 2012
    ..The Radiation Oncology Institute commissioned an independent, comprehensive assessment of research needs for the advancement of radiation oncology care...
  13. ncbi Mitigation of late renal and pulmonary injury after hematopoietic stem cell transplantation
    Eric P Cohen
    Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, USA
    Int J Radiat Oncol Biol Phys 83:292-6. 2012
    ....
  14. ncbi Dosimetric advantages of IMRT simultaneous integrated boost for high-risk prostate cancer
    X Allen Li
    Department of Radiation Oncology, Medical College of Wisconsin, 8701 Watertown Plank, Milwaukee, WI 53226, USA
    Int J Radiat Oncol Biol Phys 61:1251-7. 2005
    ..In addition, we introduce the concept of voxel-equivalent dose for the comparison of treatment plans...
  15. ncbi Quality assurance methods for the first Radiation Therapy Oncology Group permanent prostate implant protocol
    Michael T Gillin
    Department of Radiation Physics, The University of Texas M D Anderson Cancer Center, Houston, TX 77030 4009, USA
    Brachytherapy 5:152-6. 2006
    ....
  16. ncbi Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma--long-term results of phase III RTOG 85-31
    Miljenko V Pilepich
    University of California, Los Angeles, School of Medicine, Los Angeles, CA, USA
    Int J Radiat Oncol Biol Phys 61:1285-90. 2005
    ..Radiation Therapy Oncology Group protocol 85-31 was designed to evaluate the effectiveness of adjuvant androgen suppression, using goserelin, in unfavorable prognosis carcinoma of the prostate treated with definitive radiotherapy (RT)...
  17. ncbi Effect of a short course of neoadjuvant hormonal therapy on the response to subsequent androgen suppression in prostate cancer patients with relapse after radiotherapy: a secondary analysis of the randomized protocol RTOG 86-10
    William U Shipley
    Massachusetts General Hospital, Boston, MA 02114, USA
    Int J Radiat Oncol Biol Phys 54:1302-10. 2002
    ....